Aprotinin Inhibits Vascular Smooth Muscle Cell Inflammation and Proliferation via Induction of HO-1

  • Lee, Dong-Hyup (Department of Cardiac Surgery, College of Medicine, Yeungnam University) ;
  • Choi, Hyoung-Chul (Department of Pharmacology and Aging-associated Vascular Disease Research Center, College of Medicine, Yeungnam University) ;
  • Lee, Kwang-Youn (Department of Pharmacology and Aging-associated Vascular Disease Research Center, College of Medicine, Yeungnam University) ;
  • Kang, Young-Jin (Department of Pharmacology and Aging-associated Vascular Disease Research Center, College of Medicine, Yeungnam University)
  • Published : 2009.04.30

Abstract

Aprotinin is used clinically in cardiopulmonary bypass surgery to reduce transfusion requirements and the inflammatory response. The mechanism of action for the anti-inflammatory effects of aprotinin is still unclear. We examined our hypothesis whether inhibitory effects of aprotinin on cytokine-induced inducible nitric oxide synthase (iNOS) expression (IL-$l\beta$ plus TNF-$\alpha$), reactive oxygen species (ROS) generation, and vascular smooth muscle cell (VSMC) proliferation were due to HO-l induction in rat VSMCs. Aprotinin induced HO-l protein expression in a dose-dependent manner, which was potentiated during inflammatory condition. Aprotinin reduced cytokine mixture (CM)-induced iNOS expression in a dose dependent manner. Furthermore, aprotinin reduced CM-induced ROS generation, cell proliferation, and phosphorylation of JNK but not of P38 and ERK1/2 kinases. Aprotinin effects were reversed by pre-treatment with the HO-l inhibitor, tin protoporphyrin IX (SnPPIX). HO-l is therefore closely involved in inflammatory-stimulated VSMC proliferation through the regulation of ROS generation and JNK phosphorylation. Our results suggest a new molecular basis for aprotinin anti-inflammatory properties.

Keywords

References

  1. Asimakopoulos G, Thompson R, Nourshargh S, Lidington EA, Mason JC, Ratnatunga CP, Haskard DO, Taylor KM, Landis RC. An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg 120: 361−369, 2000 https://doi.org/10.1067/mtc.2000.106323
  2. Brister SJ, Ofosu FA, Buchanan MR. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant? Thromb Haemost 70: 259−262, 1993
  3. Clark JE, Foresti R, Green CJ, Motterlini R. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 348: 615−619, 2000 https://doi.org/10.1042/0264-6021:3480615
  4. Day JR, Taylor KM, Lidington EA, Mason JC, Haskard DO, Randi AM, Landis RC. Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1. J Thorac Cardiovasc Surg 131: 21−27, 2006 https://doi.org/10.1016/j.jtcvs.2005.08.050
  5. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7: 693−698, 2001 https://doi.org/10.1038/89068
  6. Durante W, Kroll MH, Christodoulides N, Peyton KJ, Schafer AI. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 80: 557−64, 1997
  7. Hill GE, Springall DR, Robbins RA. Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass. Surgery 121: 449−455, 1997 https://doi.org/10.1016/S0039-6060(97)90316-0
  8. Guikema BJ, Ginnan R, Singer HA, Jourd'heuil D. Catalase potentiates interleukin-1beta-induced expression of nitric oxide synthase in rat vascular smooth muscle cells. Free Radic Biol Med 38: 597−605, 2005 https://doi.org/10.1016/j.freeradbiomed.2004.11.022
  9. Johnson RA, Lavesa M, Askari B, Abraham NG, Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 25: 166−169, 1995
  10. Juan SH, Cheng TH, Lin HC, Chu YL, Lee WS. Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochem Pharmacol 69: 41−48, 2005 https://doi.org/10.1016/j.bcp.2004.09.015
  11. Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase- 1-deficient mouse. Am J Pathol 165: 1045−1053, 2004
  12. Keyse SM, Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA 86: 99−103, 1989 https://doi.org/10.1073/pnas.86.1.99
  13. Landis RC, Asimakopoulos G, Poullis M, Haskard DO, Taylor KM. The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg 72: 2169−2175, 2001 https://doi.org/10.1016/S0003-4975(01)02821-1
  14. Landis RC, Haskard DO, Taylor KM. New antiinflammatory and platelet-preserving effects of aprotinin. Ann Thorac Surg 72: S1808−1813, 2001 https://doi.org/10.1016/S0003-4975(01)03193-9
  15. Lee TS, Chang CC, Zhu Y, Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110: 1296−1302, 2004. https://doi.org/10.1161/01.CIR.0000140694.67251.9C
  16. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8: 240−246, 2002 https://doi.org/10.1038/nm0302-240
  17. Lee TS, Tsai HL, Chau LY. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti- inflammatory effect of low dose 15-deoxy-$\Delta^{12,14}$-prostaglandin $J_{2}$. J Biol Chem 278: 19325−19330, 2003 https://doi.org/10.1074/jbc.M300498200
  18. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 2: 2557−2568, 1988 https://doi.org/10.1096/fasebj.2.10.3290025
  19. McCoubrey WK Jr, Huang TJ, Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Bioche 247: 725−732, 1997 https://doi.org/10.1111/j.1432-1033.1997.00725.x
  20. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, Kourembanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA 98: 8798−8803, 2001 https://doi.org/10.1073/pnas.161272598
  21. Motterlini R, Foresti R, Intaglietta M, Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physio 270: H107−H114, 1996 https://doi.org/10.1152/ajpcell.1996.270.1.C107
  22. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Bach FH, Choi AM, Soares MP. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9: 183−190, 2003 https://doi.org/10.1038/nm817
  23. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase deficient cells. Proc Natl Acad Sci USA 94: 10925−10930, 1997 https://doi.org/10.1073/pnas.94.20.10925
  24. Poullis M, Manning R, Laffan M, Haskard DO, Taylor KM, Landis RC. The antithrombotic effect of aprotinin: actions mediated via the protease activated receptor 1. J Thorac Cardiovasc Surg 120: 370−378, 2000 https://doi.org/10.1067/mtc.2000.108531
  25. Tenhunen R, MArver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme owygenase. Proc Natl Acad Sci USA 61: 748−755, 1968 https://doi.org/10.1073/pnas.61.2.748
  26. Wachtfogel YT, Kucich U, Hack CE, Gluszko P, Niewiarowski S, Colman RW, Edmunds LH Jr. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg 106: 1−9, 1993
  27. Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 100: 589−596, 1997 https://doi.org/10.1172/JCI119569
  28. Westaby S. Aprotinin in perspective. Ann Thorac Surg 55: 1033−1041, 1993 https://doi.org/10.1016/0003-4975(93)90149-C
  29. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129−135, 1999 https://doi.org/10.1172/JCI4165
  30. Yoshinaga T, Sassa S, Kappas A. Purification and properties of bovine spleen heme oxygenase: amino acid composition and sites of action of inhibitors of heme oxygenase. J Biol Chem 257: 7778−7785, 1982